Location History:
- Oak Park, CA (US) (2008 - 2014)
- Oaks Park, CA (US) (2017)
Company Filing History:
7 out of 1,974 
4 out of 152 
1 out of 1,624 
Years Active: 2008-2017
Title: Xueming Qian: Innovator in Monoclonal Antibody Development
Introduction
Xueming Qian is a prominent inventor based in Oak Park, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic monoclonal antibodies. With a total of 7 patents to his name, Qian's work has the potential to impact the treatment of various diseases.
Latest Patents
Among his latest patents is the therapeutic human anti-IL-1R1 monoclonal antibody. This invention describes antibodies that interact with interleukin-1 receptor type 1 (IL-1R1). The patent outlines methods for treating IL-1 mediated diseases by administering a pharmaceutically effective amount of these antibodies. Additionally, it includes methods for detecting the amount of IL-1R1 in a sample using antibodies specific to IL-1R1.
Career Highlights
Qian has worked with notable companies in the biotechnology sector, including Amgen Inc. and Medarex Inc. His experience in these organizations has allowed him to refine his expertise in antibody development and therapeutic applications.
Collaborations
Throughout his career, Qian has collaborated with esteemed colleagues such as Brian C. Varnum and Chris Vezina. These partnerships have contributed to the advancement of his research and innovations in the field.
Conclusion
Xueming Qian's contributions to monoclonal antibody development exemplify the impact of innovation in biotechnology. His patents and collaborations highlight his commitment to advancing medical treatments and improving patient outcomes.